| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.006 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |